Thomas Malley

Insider Reports History

Entity
Individual
Location
C/O Kiniksa Pharmaceuticals, Ltd., Clarendon House, 2 Church Street, Hamilton, Bermuda
Signature
/s/ Madelyn Zeylikman, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Thomas Malley:

Stock Role Class Num Shares Value Price $ Report Date Ownership
BeiGene, Ltd. Director Ordinary Shares 46.7K $9.7M $207.72 Jun 15, 2023 Direct
BeiGene, Ltd. Director American Depositary Shares 30K $5.42M $180.50 Jun 15, 2023 Direct
Kura Oncology, Inc. Director Common stock 140K $1.6M $11.50 Jun 16, 2023 By Mossrock Capital, LLC
Kiniksa Pharmaceuticals, Ltd. Director Class A Common Shares 72K Jun 5, 2024 Indirect
BeiGene, Ltd. Director Share Option (Right to Buy) 27K Jun 15, 2023 Direct
Kura Oncology, Inc. Director Option to purchase common stock 26K Jun 5, 2024 Direct
Kiniksa Pharmaceuticals, Ltd. Director Share Option 19K Jun 5, 2024 Direct
Kiniksa Pharmaceuticals, Ltd. Director Class A Common Shares 9.37K Jun 6, 2024 Direct
Kiniksa Pharmaceuticals, Ltd. Director Restricted Share Units 0 Jun 6, 2024 Direct

Insider Reports Filed by Thomas Malley

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KNSA Kiniksa Pharmaceuticals, Ltd. Jun 5, 2024 4 $0 4 Jun 7, 2024 Director
KURA Kura Oncology, Inc. Jun 5, 2024 1 $0 4 Jun 7, 2024 Director
KNSA Kiniksa Pharmaceuticals, Ltd. Jun 29, 2023 2 $0 4 Jul 3, 2023 Director
KURA Kura Oncology, Inc. Jun 16, 2023 1 $575K 4 Jun 21, 2023 Director
BGNE BeiGene, Ltd. Jun 15, 2023 2 $0 4 Jun 20, 2023 Director
KNSA Kiniksa Pharmaceuticals, Ltd. Jun 6, 2023 2 $0 4 Jun 8, 2023 Director
KURA Kura Oncology, Inc. May 31, 2023 1 $0 4 Jun 2, 2023 Director
KNSA Kiniksa Pharmaceuticals, Ltd. Jun 29, 2022 2 $0 4 Jun 30, 2022 Director
BGNE BeiGene, Ltd. Jun 22, 2022 2 $0 4 Jun 24, 2022 Director
KURA Kura Oncology, Inc. Jun 21, 2022 1 $0 4 Jun 23, 2022 Director
KNSA Kiniksa Pharmaceuticals, Ltd. Jun 29, 2021 1 $0 4 Jun 30, 2021 Director
KURA Kura Oncology, Inc. Jun 22, 2021 1 $0 4 Jun 23, 2021 Director
BGNE BeiGene, Ltd. Jun 16, 2021 2 $0 4 Jun 21, 2021 Director